Drug Delivery

Tiziana rethinks oral antibody trial amid feasibility problems

By Nick Paul Taylor

Tiziana Life Sciences has filed an amendment to get its oral antibody program back on track. After hitting a roadblock with its initial design, Tiziana has expanded the patient population and shortened the dosing period in a bid to wrap up the phase 1b by the end of the year. 

read more

Moffitt Dyves back into tumor pH modulation, turning to transdermal delivery to bypass oral barriers

By Nick Paul Taylor

Dyve Biosciences is offering Moffitt Cancer Center a way around a long-standing drug delivery problem. After seeing patients repeatedly reject their oral cancer therapy, researchers at Moffitt have teamed up with Dyve to collaborate on the development of a transdermal formulation.

read more

Top 10 most anticipated drug launches of 2022

By Ben Adams

After 55 new drug approvals at the FDA last year, biopharma and the U.S. agency are still going all guns blazing in getting new therapies out to patients. But what are the most hotly tipped—and potentially most lucrative—approvals on the horizon for 2022?

read more

Research: How Buffer Prep Services Alleviate Sudden Spikes in Campaign Volume

Sponsored by: Thermo Fisher Scientific

Learn how a CDMO partnered with Thermo Fisher Scientific to manage high-volume process liquid and buffer preparation scale-up. Download the free case study from Thermo Fisher Scientific

Whitepaper: QC for ex vivo manipulated cell lines and tissues

Sponsored by: Thermo Fisher Scientific

A variety of genetic analysis methods are valuable in ensuring that ex vivo human cells to be used for cell-based therapies are correctly identified, have the correct characteristics, and are free of contaminants.

Webinar: Using Next Best to Elevate your Omnichannel Marketing Strategy

Sponsored by: IQVIA

Learn how to elevate your omnichannel marketing strategy with Next Best - a combination of data and analytics, deployed to facilitate decision making.

Webinar: The Faster Path From Pre-Filled Syringe to Auto-Injector

Sponsored by: Catalent Biologics

Ypsomed and Catalent Biologics experts discuss strategies for integrated PFS manufacturing and auto-injector assembly to accelerate timelines and more in this webinar.

Whitepaper: Formulation Strategies When Transitioning From Vial to PFS

Sponsored by: Catalent Biologics

Learn how formulation development for a PFS affects manufacturing to drive the industry toward optimizing delivery of injectable products and, ultimately, improving patient care.

Whitepaper: Enhance the cost-effectiveness of your cGMP chemical supply chain

Sponsored by: Thermo Fisher Scientific

Learn how to develop a high-performing supply chain for cGMP chemicals used throughout your biologics workflow. Download the free whitepaper from Thermo Fisher Scientific

eBook: Get solutions to market faster

Sponsored by: Box

Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization.